光大保德信健康优加混合A
Search documents
阳光诺和股价跌5.05%,光大保德信基金旗下1只基金重仓,持有34.39万股浮亏损失126.56万元
Xin Lang Cai Jing· 2026-01-26 22:41
Group 1 - The core point of the news is that Yangguang Nuohuo's stock price has dropped by 5.05%, currently trading at 69.15 yuan per share, with a total market capitalization of 7.745 billion yuan [1] - Yangguang Nuohuo is primarily engaged in the development of generic drugs, consistency evaluation, and innovative drug development, with 99.91% of its revenue coming from CRO services [1] - The company was established on March 9, 2009, and went public on June 21, 2021, located in Changping District, Beijing [1] Group 2 - According to data, the fund "Guangda Baodexin Health Youjia Mixed A" holds a significant position in Yangguang Nuohuo, having reduced its holdings by 83,700 shares in the fourth quarter, now holding 343,900 shares, which represents 2.8% of the fund's net value [2] - The fund has a total scale of 761 million yuan and has achieved a return of 5.95% this year, ranking 4476 out of 9003 in its category [2] - The fund manager, Xu Xiaojie, has been in position for 10 years and 260 days, with the best fund return during this period being 203.27% [3]
光大保德信红利混合A:2025年第二季度利润1048.46万元 净值增长率4.05%
Sou Hu Cai Jing· 2025-07-21 10:20
Core Viewpoint - The AI Fund Everbright Prudential Dividend Mixed A (360005) reported a profit of 10.48 million yuan for Q2 2025, with a net asset value growth rate of 4.05% during the period [3][17]. Fund Performance - As of July 18, the fund's unit net value was 1.839 yuan, with a one-year return of 6.53%, ranking 521 out of 601 comparable funds [3][4]. - The fund's three-month return was 8.50%, ranking 402 out of 607, and the six-month return was 9.87%, ranking 348 out of 607 [4]. - Over the past three years, the fund's return was -11.71%, ranking 228 out of 468 [4]. Risk Metrics - The fund's Sharpe ratio over the past three years was -0.1408, ranking 341 out of 468 [10]. - The maximum drawdown over the past three years was 29.06%, with the largest single-quarter drawdown occurring in Q1 2021 at 17.55% [12]. Fund Holdings - As of Q2 2025, the fund's top ten holdings included Kelun Pharmaceutical, Zhaoyi Innovation, Bank of China, CITIC Bank, Huahai Pharmaceutical, China Construction Bank, Ningbo Bank, Yangtze Power, China Shenhua, and Chongqing Rural Commercial Bank [21]. - The average stock position over the past three years was 79.12%, compared to the industry average of 85.36% [15].